duosulfa - rizultati | myHealthbox

Stati Uniti - Ingliż - NLM (National Library of Medicine)

myleran- busulfan tablet, film coated

woodward pharma services llc - busulfan (unii: g1ln9045dk) (busulfan - unii:g1ln9045dk) - myleran (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia. myleran is contraindicated in patients in whom a definitive diagnosis of chronic myelogenous leukemia has not been firmly established. myleran is contraindicated in patients who have previously suffered a hypersensitivity reaction to busulfan or any other component of the preparation.

Stati Uniti - Ingliż - NLM (National Library of Medicine)

myleran- busulfan tablet, film coated

waylis therapeutics llc - busulfan (unii: g1ln9045dk) (busulfan - unii:g1ln9045dk) - myleran (busulfan) is indicated for the palliative treatment of chronic myelogenous (myeloid, myelocytic, granulocytic) leukemia. myleran is contraindicated in patients in whom a definitive diagnosis of chronic myelogenous leukemia has not been firmly established. myleran is contraindicated in patients who have previously suffered a hypersensitivity reaction to busulfan or any other component of the preparation.

Iżrael - Ingliż - Ministry of Health

busulfex

tzamal bio-pharma ltd - busulfan - solution for injection - busulfan 60 mg / 10 ml - busulfan - for use in combination with other chemotherapeutic agents and/or radiotherapy as a conditioning regimen prior to hematopoietic progenitor cell transplantation.

Iżrael - Ingliż - Ministry of Health

myleran tablets 2 mg

padagis israel agencies ltd, israel - busulfan - tablets - busulfan 2 mg - busulfan - for the palliative treatment of the chronic granulocytic leukemia.